Program of Research for the Optimization of a Supervised Patient Pathway for Expectant According to Risk in Obstetrics
PROSPERO
1 other identifier
interventional
1,532
1 country
2
Brief Summary
This French multicentre open-label randomized trial will test the hypothesis that a coordinated health circuit based on obstetric risks, backed up by an electronic patient care reporting information system will optimize the continuum of pregnancy care monitoring. The electronic patient care reporting information system will be shared between patients, private practice physicians/midwifes, hospital physicians/midwifes and supervised by a coordinating midwife.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pregnancy
Started Dec 2016
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2015
CompletedFirst Posted
Study publicly available on registry
November 2, 2015
CompletedStudy Start
First participant enrolled
December 5, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedSeptember 3, 2025
August 1, 2025
1.6 years
October 28, 2015
August 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of patients'pathway approved as compliant in the intervention group compared to the control group.
Compliant patient pathways are those for which all actions (medical visits, examinations, …) recommended during pregnancy, according to the specific risk factors of each patient, will have been made.
at the end of pregnancy
Secondary Outcomes (10)
rate of severe maternal morbidity and mortality as defined by the EPIdémiologie de la MOrbidité Maternelle Sévère (EPINOMS) project
From 22 completed weeks (154 days) of gestation to seven completed days after birth
rate of perinatal morbidity-mortality as defined by the Organization, Practices Evaluation in perinatal Network
From 22 completed weeks (154 days) of gestation to seven completed days after birth
completeness of all hospital medical records
the end of pregnancy (the date of delivery)
health care costs
one week from the date of delivery
health care costs
one week from the date of delivery
- +5 more secondary outcomes
Study Arms (2)
PROSPERO group (intervention group)
ACTIVE COMPARATORcontrol group
PLACEBO COMPARATORInterventions
The intervention is carried out in 3 steps: 1. At the start of the pregnancy: a number of process steps are defined for a patient's pathway adapted to medical, obstetric and social risk factors. 2. During pregnancy: city based doctors and midwives work together with their hospital peers enabling patients to participate through the reporting via a medical information system 3. The entrance in the delivery room: patients are classified as low or high risk for greater vigilance from midwives.
At the start of the pregnancy, medical, obstetric and social risk factors are checked in the same way than the PROSPERO group. An adapted patient pathway was defined by a Clinical Research Assistant but unreachable from patients, midwifes and physicians. The electronic patient care reporting information system will be disabled and midwifes cannot create the classification checklist for low or high risk delivery.
Eligibility Criteria
You may qualify if:
- patients over the age of majority,
- enrolled in one of the two maternity hospitals in the study before 12 weeks of amenorrhea (SA) and 6 days (j) of age,
- affiliated to the National Health Insurance Fund of the country within the regional level health insurance
- have an internet access
You may not qualify if:
- illiterate patients,
- non-French speakers,
- under the age of majority,
- refusing to participate,
- without internet access,
- followed by one of these maternity wards but delivering else where,
- whose pregnancy ended in a miscarriage early or late (before 21 weeks of amenorrhea (SA) and 6 days (J) over).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hôpital Femme Mère Enfant
Bron, 69677, France
Hospices Civils de Lyon
Lyon, 69002, France
Related Publications (1)
Gaucher L, Puill C, Baumann S, Hommey S, Touzet S, Rudigoz RC, Cortet M, Huissoud C, Gaucherand P, Dupont C, Mougeot F. The challenge of adopting a collaborative information system for independent healthcare workers in France: a comprehensive study. Sci Rep. 2024 May 19;14(1):11429. doi: 10.1038/s41598-024-62164-2.
PMID: 38763960BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
René-Charles RUDIGOZ, Pr
Hospices Civils de Lyon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 28, 2015
First Posted
November 2, 2015
Study Start
December 5, 2016
Primary Completion
July 1, 2018
Study Completion
July 1, 2018
Last Updated
September 3, 2025
Record last verified: 2025-08